Sanofi Logo

Sanofi

Global biopharma firm researching, developing & marketing prescription medicines & vaccines.

SAN | PA

Overview

Corporate Details

ISIN(s):
FR0000120578 (+39 more)
LEI:
549300E9PC51EN656011
Country:
France
Address:
46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sanofi is a global biopharmaceutical company engaged in the research, development, manufacturing, and marketing of therapeutic solutions, primarily prescription medicines and vaccines. The company leverages science and digital technologies, including AI, to discover and deliver treatments across various healthcare areas. With a worldwide presence, Sanofi operates through multiple divisions and specialized R&D-focused subsidiaries like Ablynx, Kymab, and Principia to advance its pipeline. It aims to transform the practice of medicine and improve public health by providing innovative healthcare products to millions of people globally. The company also manufactures and supplies active pharmaceutical ingredients through its Sanofi Active Ingredient Solutions arm.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-06 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 6.4 MB
2025-10-06 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 6.3 MB
2025-09-29 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.4 MB
2025-09-29 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB
2025-09-22 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.4 MB
2025-09-22 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB
2025-09-15 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.6 MB
2025-09-15 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 444.0 KB
2025-09-12 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Information concerning the total number of voting rights and shares - A…
English 136.1 KB
2025-09-12 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Informations relatives au nombre de droits de vote et d'actions - AOUT …
French 112.1 KB
2025-09-02 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.9 MB
2025-09-02 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.9 MB
2025-08-25 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB
2025-08-18 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.7 MB
2025-08-18 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juill…
French 121.9 KB

Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Sanofi via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-05-02 N/A Other Buy 71,423 N/A
2024-04-26 N/A Other Buy 1,000 91,380.00 EUR
2023-06-09 N/A Other Buy 9 856.04 EUR
2023-05-02 N/A Other Buy 65,205 6,364,008.00 EUR
2023-05-02 N/A Other Buy 500 48,835.00 EUR

Peer Companies

Company Country Ticker View
Galderma Group AG Logo
A pure-play dermatology company with aesthetics, skincare, and therapeutic solutions.
Switzerland GALD
GC CELL CORPORATION Logo
Biotech firm offering cell/gene therapy CDMO services and developing immune cell cancer therapies.
South Korea 144510
GemVax & KAEL Co.,Ltd. Logo
Makes contamination controls for semiconductors & develops Alzheimer's therapeutics.
South Korea 082270
Gencurix Inc. Logo
Develops molecular diagnostic tests for cancer detection, prognosis, and treatment selection.
South Korea 229000
GENEMATRIX INC. Logo
Develops multiplex PCR diagnostics and new drugs for infectious diseases like HPV and tuberculosis.
South Korea 109820
GeneOne Life Science, Inc. Logo
Develops nucleic acid vaccines & therapies for infectious diseases, cancer & autoimmune disorders.
South Korea 011000
Genetic Analysis AS Logo
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
Norway GEAN
GENFIT Logo
Biopharma developing therapies & diagnostics for rare, life-threatening liver diseases.
France GNFT
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye GENIL
Genmab Logo
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
Denmark GMAB

Talk to a Data Expert

Have a question? We'll get back to you promptly.